Risk of low blood sugar differs among similar diabetes drugs

Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or hypoglycemia. SUs -- which include newer generation agents such as gliclazide, glipizide, glimepiride, and glibenclamide -- stimulate the production of insulin in the pancreas and increase the effectiveness of insulin in the body.
Source: ScienceDaily Headlines - Category: Science Source Type: news

Related Links:

Publication date: 7 April 2020Source: Cell Reports, Volume 31, Issue 1Author(s): Christian M. Cohrs, Julia K. Panzer, Denise M. Drotar, Stephen J. Enos, Nicole Kipke, Chunguang Chen, Robert Bozsak, Eyke Schöniger, Florian Ehehalt, Marius Distler, Ana Brennand, Stefan R. Bornstein, Jürgen Weitz, Michele Solimena, Stephan Speier
Source: Cell Reports - Category: Cytology Source Type: research
Source: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy - Category: Endocrinology Tags: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Source Type: research
TYPE 2 diabetes is a chronic condition that requires you to take extra care of your health to prevent high blood sugar levels. Diet plays a key role here and evidence suggests there are some items you shouldn't go without, including a particular supplement.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Authors: Choi JB, Yoo JM, Lee YJ, Kim JW, Lee SJ, Kim HY, Lee DS, Ko SH, Choe HS Abstract PURPOSE: To investigate the effect of dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, on inflammatory cytokines of urogenital tissue in a rat model of type 2 diabetes (T2DM) to infer pharmaceutical influence of dapagliflozin on genitourinary infection or inflammation. METHODS: Study animals were divided into the following 4 groups of 10 animals each: (1) the Otsuka Long-Evans Tokushima Fatty (OLETF)-DA group treated with dapagliflozin at 1.0 mg/kg/day, (2) the OLETF-VO group treated with voglibose at 0.6 mg/kg/d...
Source: International Neurourology Journal - Category: Urology & Nephrology Tags: Int Neurourol J Source Type: research
We often think of self-development as a pursuit that builds positive capabilities such as courage, ambition, or a success mindset. And of course it can generate many positive results if we truly invest in it, such as loving relationships, a meaningful and lucrative career, and a rewarding lifestyle. But we can easily overlook just how beautifully self-development protects us from major problems in life, including serious but common problems that drag many people down for years, if not decades. Preventing Self-Destruction I originally got into self-development as a path away from self-destructive behavior when I wa...
Source: Steve Pavlina's Personal Development Blog - Category: Psychiatry & Psychology Authors: Tags: Health Lifestyle Source Type: blogs
Publication date: Available online 7 April 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Vahideh Behrouz, Ali Dastkhosh, Golbon Sohrab
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
Publication date: Available online 9 December 2019Source: Canadian Journal of DiabetesAuthor(s): Lingning Huang, Yongze Zhang, Yunmin Wang, Ximei Shen, Sunjie Yan
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
(JAMA Network) Metformin is the most commonly prescribed noninsulin medication for type 2 diabetes and this observational study examined postoperative death and hospital readmission among adults with type 2 diabetes who had a prescription for metformin before major surgery with those who didn't.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news
Publication date: Available online 7 April 2020Source: Academic PediatricsAuthor(s): Marcela Osorio, Christian A. Koziatek, Mary Pat Gallagher, Jessie Recaii, Meryle Weinstein, Lorna E. Thorpe, Brian Elbel, David C. Lee
Source: Academic Pediatrics - Category: Pediatrics Source Type: research
This cohort study describes the mortality and readmission outcomes of prescribing metformin beyond its use to control blood glucose levels in adults with type 2 diabetes.
Source: JAMA Surgery - Category: Sports Medicine Source Type: research
More News: Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Glimepiride | Glipizide | Insulin | Metformin | Pancreas | Science